Kinoshita Ryo, Nishiura Hiroshi
Graduate School of Medicine, Hokkaido University, Kita 15 Jo Nishi 7 Chome, Kita-ku, Sapporo, Hokkaido 060-9638, Japan; CREST, Japan Science and Technology Agency, Honcho 4-1-8, Kawaguchi, Saitama 332-0012, Japan.
Graduate School of Medicine, Hokkaido University, Kita 15 Jo Nishi 7 Chome, Kita-ku, Sapporo, Hokkaido 060-9638, Japan; CREST, Japan Science and Technology Agency, Honcho 4-1-8, Kawaguchi, Saitama 332-0012, Japan.
Vaccine. 2017 Jun 5;35(25):3309-3317. doi: 10.1016/j.vaccine.2017.05.011. Epub 2017 May 10.
Routine vaccination against measles in Japan started in 1978. Whereas measles elimination was verified in 2015, multiple chains of measles transmission were observed in 2016. We aimed to reconstruct the age-dependent susceptibility to measles in Japan so that future vaccination strategies can be elucidated.
An epidemiological model was used to quantify the age-dependent immune fraction using datasets of vaccination coverage and seroepidemiological survey. The second dose was interpreted in two different scenarios, i.e., booster and random shots. The effective reproduction number, the average number of secondary cases generated by a single infected individual, and the age at infection were explored using the age-dependent transmission model and the next generation matrix.
While the herd immunity threshold of measles likely ranges from 90% to 95%, assuming that the basic reproductive number ranges from 10 to 20, the estimated immune fraction in Japan was below those thresholds in 2016, despite the fact that the estimates were above 80% for all ages. If the second dose completely acted as the booster shot, a proportion immune above 90% was achieved only among those aged 5years or below in 2016. Alternatively, if the second dose was randomly distributed regardless of primary vaccination status, a proportion immune over 90% was achieved among those aged below 25years. The effective reproduction number was estimated to range from 1.50 to 3.01 and from 1.50 to 3.00, respectively, for scenarios 1 and 2 in 2016; if the current vaccination schedule were continued, the reproduction number is projected to range from 1.50 to 3.01 and 1.39 to 2.78, respectively, in 2025.
Japan continues to be prone to imported cases of measles. Supplementary vaccination among adults aged 20-49years would be effective if the chains of transmission continue to be observed in that age group.
日本于1978年开始实施常规麻疹疫苗接种。尽管2015年已证实消除了麻疹,但2016年仍观察到多条麻疹传播链。我们旨在重建日本不同年龄段对麻疹的易感性,以便阐明未来的疫苗接种策略。
使用流行病学模型,利用疫苗接种覆盖率和血清流行病学调查数据集来量化不同年龄段的免疫比例。对第二剂疫苗的接种情况采用两种不同的假设情景进行解读,即加强免疫和随机接种。使用年龄依赖性传播模型和下一代矩阵,探讨有效繁殖数、单个感染个体产生的二代病例平均数量以及感染年龄。
假设基本繁殖数在10至20之间,麻疹的群体免疫阈值可能在90%至95%之间,尽管2016年日本各年龄段的估计免疫比例均高于80%,但仍低于这些阈值。如果第二剂疫苗完全起到加强免疫的作用,2016年只有5岁及以下人群的免疫比例达到90%以上。或者,如果第二剂疫苗不论初次接种情况随机接种,25岁以下人群的免疫比例可达到90%以上。2016年情景1和情景2的有效繁殖数估计分别为1.50至3.01和1.50至3.00;如果继续沿用当前的疫苗接种计划,预计2025年的繁殖数分别为1.50至3.01和1.39至2.78。
日本仍然容易出现麻疹输入病例。如果在20至49岁年龄组继续观察到传播链,对该年龄组的成年人进行补充接种将是有效的。